Qsemble Capital Management, LP Incyte Corp Call Options Transaction History
Qsemble Capital Management, LP
- $527 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding INCY
# of Institutions
625Shares Held
198MCall Options Held
763KPut Options Held
476K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.53 Billion24.77% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.76 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.4MShares$1.68 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA15.3MShares$1.26 Billion0.58% of portfolio
-
State Street Corp Boston, MA10.9MShares$894 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $18.3B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...